KCT0001116已完成未知
A Randomized, Open-label, Single-dose, 2-Way Cross-over Study to Compare the Safety and the Pharmacokinetic Characteristics of the Co-administration of Rosuvastatin and Metformin SR and YH14755 and to Investigate the Effect of Food on the Pharmacokinetics of YH14755 in Healthy Volunteers
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- Yuhan
- 入组人数
- 56
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 55(Year)（—）
- 性别
- All
入选标准
- •1. Healthy male and female with a body mass index(BMI) between 18.5 and 25 kg/m2
- •2. Who has not suffered from clinically significant disease
- •3. Provision of signed written informed consent
排除标准
- •1.History of and clinically significant disease
- •2. A history of drug abuse or the presence of positive reactions to drugs that have abuse potential in urine screenings for drugs.
- •3. Administration of other investigational products within 3 months prior to the first dosing.
- •4. Administration of herbal medicine within 4 weeks or administration of ethical drugs within 2 weeks or administration of over-the-counter (OTC) drugs within 1 week prior to the first dosing of the investigational product (if the investigator (study doctor) determines that the person meets other criteria appropriately, the relevant person may participate in the study).
- •5. Volunteers considered not eligible for the clinical trial by the investigator (study doctor) due to reasons including laboratory test results, ECGs, or vital signs.
研究者
相似试验
已完成
不适用
A Phase 1 Clinical Trial to Investigate Pharmacokinetics and Bioequivalence of the co-administration of telmisartan and rosuvastatin and YH16410KCT0001231Yuhan180
进行中（未招募）
不适用
A randomized, open-label, single-dose, 2-way cross-over study to compare the safety and the pharmacokinetic characteristics of CPBI402 in healthy male volunteersDiseases of The genitoruinary systemKCT0001767Corepharmbio34
招募中
不适用
A Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Combination of Rosuvastatin and CS-866 and DWJ1276 in Healthy Male VolunteersKCT0000325Yonsei University Health System, Severance Hospital58
进行中（未招募）
不适用
A single-dose, open-label, randomized, 2-way crossover, clinical pharmacology study of four inhalations of CHF 1535 100/6 NEXT DPI® (fixed combination of beclomethasone dipropionate 100µg plus formoterol fumarate 6 µg) versus the same dose of CHF 1535 100/6 pMDI both administered with charcoal block. - (duplicate) Clinical pharmacology study of CHF1535 NEXT DPI versus CHF1535 pMDIMedDRA version: 13.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersAsthmaEUCTR2010-024384-40-GBChiesi Farmaceutici S.p.A.24
招募中
不适用
An open-label, randomized, single-dose, 2way crossover study to compare the pharmacokinetics of Traclear 62.5 mg 2 tablets and HGP1206 125 mg 1 tablet in healthy male volunteersKCT0000802Hanmi Pharm28